DEA probes Done Global for telehealth prescriptions of ADHD meds

U.S. Drug Enforcement Administration agents have begun investigating telehealth provider Done Global Inc.’s practices for prescribing controlled substances, reports Fierce Healthcare. Done is a membership-based platform that connects patients seeking treatment for attention-deficit hyperactivity disorder with qualified clinicians. Federal authorities are increasingly scrutinizing telehealth companies that prescribe stimulants like Adderall for treatment of ADHD.